ArticleEJHaem2026

Reduced Pathogen-Specific T Cell Response With BCMA-Targeted T Cell-Engaging Therapy to Multiple Myeloma.

Ida Steiro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.